IP and Patents

viagra ppt affected speech prayer for thesis oral defense get link follow 4th of july celebration essay need help writing term paper viagra online and pay with paypal https://www.puente.org/exams/how-do-i-change-ipad-name/13/ annotated bibliography assignment https://masterpieceministries.org/best-dissertation-abstract-editor-site-usa/ https://groups.csail.mit.edu/cb/paircoil2/?pdf=how-to-write-i-owe-you https://campcaroline.org/samples-of-good-resume-singapore/ follow site pfizer brand viagra for sale http://www.salganyc.org/8375-no-presription-viagra-pharmacy-reviews/ viagra 50 mg pfizer get link online valtrex http://flahertyseminar.org/graduate/paper-mate-sharpwriter-eraser-refill/28/ go to site buy levitra 20 mg online cheapdrugswithoutprescription how to add audio to powerpoint presentation creative writing introduction source source url watch homework help online earth science Stemedica International has an exclusive worldwide license for Stemedica Cell Technologies’ products for neurodegenerative diseases. As part of the license, Stemedica International also has full rights to any pre-clinical and clinical protocols and results of any pre-clinical and clinical trials associated with degenerative diseases.

Patents Issued

  • Culturing ectodermal cells under reduced oxygen tension in the presence of serum and a growth factor (U.S. Patent #8420394 B2)
  • Cellular Scaffold (U.S. Patent #8709081)
  • Cellular Scaffold – includes stem cell factors (U.S. Patent #8105380)
  • Compositions of Stem Cells and Stem Cell Factors and Methods for Their Use and Manufacture (U.S. Patent #8790638)

Patent Applications Filed With the United States Patent and Trademark Office

  • Mesenchymal Stem Cell Mediated Delivery of Therapeutic Agents
  • Angiogenically Induced Transplants and Methods for Their Use and Manufacture
  • Chimeric Transplant
  • Transgenic Therapeutic Stem Cells and Methods for their Use and Manufacture

Intellectual Property

Stemedica International’s other IP assets relate to the following processes:

  • Preserving Stem Cell Differentiation Potential During Scale-Up
  • Expansion/Scale-Up of Stem Cells
  • Treatment Protocols
  • Post-Treatment Patient Protocols
  • Cell Dosages and Number of Treatments Required for Therapeutic Effect